Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
27,995,500
-
Total 13F shares
-
12,757,094
-
Share change
-
+282,864
-
Total reported value
-
$176,293,302
-
Price per share
-
$13.87
-
Number of holders
-
34
-
Value change
-
+$3,959,957
-
Number of buys
-
26
-
Number of sells
-
4
Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q3 2016
As of 30 Sep 2016,
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,757,094 shares.
The largest 10 holders included
Flagship Ventures Management, Inc., FMR LLC, DEERFIELD MANAGEMENT CO, Redmile Group, LLC, Aisling Capital LLC, BAKER BROS. ADVISORS LP, EVENTIDE ASSET MANAGEMENT, LLC, JPMORGAN CHASE & CO, BlackRock Fund Advisors, and Alyeska Investment Group, L.P..
This page lists
34
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.